1 |
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
KMSID: 1516082516 J Liver Cancer. 2023;23(1):1-120. Published online 2022 December 9 DOI: http://dx.doi.org/10.17998/jlc.2022.11.07 |
|
121 |
How to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasionHow to optimize the treatment strategy for advanced-stage hepatocellular carcinoma with macrovascular invasion
Beom Kyung KimBeom Kyung Kim
KMSID: 1516082523 J Liver Cancer. 2023;23(1):121-123. Published online 2023 March 24 DOI: http://dx.doi.org/10.17998/jlc.2023.3.10 |
|
124 |
Impact of the updated KLCA-NCC criteria for diagnosis of “probable HCC” in liver MRI: comparisons between KLCA v2022 and v2018Impact of the updated KLCA-NCC criteria for diagnosis of “probable HCC” in liver MRI: comparisons between KLCA v2022 and v2018
Jeong Hee YoonJeong Hee Yoon
KMSID: 1516082525 J Liver Cancer. 2023;23(1):124-126. Published online 2023 March 21 DOI: http://dx.doi.org/10.17998/jlc.2023.3.7 |
|
127 |
Non-alcoholic fatty liver disease-related hepatocellular carcinomaNon-alcoholic fatty liver disease-related hepatocellular carcinoma
Darine Daher, Karim Seif El Dahan, Amit G. SingalDarine Daher, Karim Seif El Dahan, Amit G. Singal
KMSID: 1516082512 J Liver Cancer. 2023;23(1):127-142. Published online 2023 February 9 DOI: http://dx.doi.org/10.17998/jlc.2022.12.30 |
|
143 |
Radiologic features of hepatocellular carcinoma related to prognosisRadiologic features of hepatocellular carcinoma related to prognosis
Shin Hye Hwang, Hyungjin RheeShin Hye Hwang, Hyungjin Rhee
KMSID: 1516082518 J Liver Cancer. 2023;23(1):143-156. Published online 2023 March 9 DOI: http://dx.doi.org/10.17998/jlc.2023.02.16 |
|
157 |
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteriaDiagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin KimJa Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
KMSID: 1516082515 J Liver Cancer. 2023;23(1):157-165. Published online 2023 February 23 DOI: http://dx.doi.org/10.17998/jlc.2023.02.07 |
|
166 |
Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective studyUse of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
Su Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun KimSu Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim
KMSID: 1516082513 J Liver Cancer. 2023;23(1):166-176. Published online 2023 March 3 DOI: http://dx.doi.org/10.17998/jlc.2023.02.08 |
|
177 |
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatmentSubclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
Sujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi ChoiSujin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
KMSID: 1516082524 J Liver Cancer. 2023;23(1):177-188. Published online 2023 March 23 DOI: http://dx.doi.org/10.17998/jlc.2023.03.04 |
|
189 |
Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter studyCurrent status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
Sun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, Jung Hyun Kwon, Han-Ah Lee, Yeon Seok Seo, Young Kul Jung, Hyung Joon Yim, Do Seon Song, Seong Hee Kang, Moon Young Kim, Young-Hwan Ahn, Jieun Han, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Jeong-Ju YooSun Hong Yoo, Soon Sun Kim, Sang Gyune Kim, Jung Hyun Kwon, Han-Ah Lee, Yeon Seok Seo, Young Kul Jung, Hyung Joon Yim, Do Seon Song, Seong Hee Kang, Moon Young Kim, Young-Hwan Ahn, Jieun Han, Young Seok Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo
KMSID: 1516082526 J Liver Cancer. 2023;23(1):189-201. Published online 2023 March 24 DOI: http://dx.doi.org/10.17998/jlc.2023.03.11 |
|
202 |
Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah’s witness: a case reportParenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah’s witness: a case report
Shehan Ratnayake, Duminda Subasinghe, Vihara Dassanayake, Sivasuriya SivaganeshShehan Ratnayake, Duminda Subasinghe, Vihara Dassanayake, Sivasuriya Sivaganesh
KMSID: 1516082514 J Liver Cancer. 2023;23(1):202-205. Published online 2023 February 15 DOI: http://dx.doi.org/10.17998/jlc.2023.01.27 |
|
206 |
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatmentA case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won ParkYuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
KMSID: 1516082517 J Liver Cancer. 2023;23(1):206-212. Published online 2023 February 24 DOI: http://dx.doi.org/10.17998/jlc.2023.02.09 |
|
213 |
A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumabA case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab
Hyung Jun Kim, Sang Youn Hwang, Jung Woo Im, Ki Jeong Jeon, Wan JeonHyung Jun Kim, Sang Youn Hwang, Jung Woo Im, Ki Jeong Jeon, Wan Jeon
KMSID: 1516082519 J Liver Cancer. 2023;23(1):213-218. Published online 2023 March 9 DOI: http://dx.doi.org/10.17998/jlc.2023.02.23 |
|
219 |
Adult hepatoblastoma: making the challenging distinction from hepatocellular carcinomaAdult hepatoblastoma: making the challenging distinction from hepatocellular carcinoma
Allison Kaye L. Pagarigan, Paulo Giovanni L. MendozaAllison Kaye L. Pagarigan, Paulo Giovanni L. Mendoza
KMSID: 1516082520 J Liver Cancer. 2023;23(1):219-224. Published online 2023 March 13 DOI: http://dx.doi.org/10.17998/jlc.2023.02.24 |
|
225 |
Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumabFavorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
Yong Tae Kim, Jina Kim, Jinsil SeongYong Tae Kim, Jina Kim, Jinsil Seong
KMSID: 1516082521 J Liver Cancer. 2023;23(1):225-229. Published online 2023 March 16 DOI: http://dx.doi.org/10.17998/jlc.2023.02.27 |
|
230 |
The development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case reportThe development of hepatocellular carcinoma during long-term treatment for recurrent non-small cell lung cancer: a case report
Seong Kyun Na, Seong Hee KangSeong Kyun Na, Seong Hee Kang
KMSID: 1516082522 J Liver Cancer. 2023;23(1):230-234. Published online 2023 March 27 DOI: http://dx.doi.org/10.17998/jlc.2023.03.03 |
|